KR960037685A - 암모니오세팔로스포린 계열 항생제 및 그의 제조방법 - Google Patents

암모니오세팔로스포린 계열 항생제 및 그의 제조방법 Download PDF

Info

Publication number
KR960037685A
KR960037685A KR1019950007864A KR19950007864A KR960037685A KR 960037685 A KR960037685 A KR 960037685A KR 1019950007864 A KR1019950007864 A KR 1019950007864A KR 19950007864 A KR19950007864 A KR 19950007864A KR 960037685 A KR960037685 A KR 960037685A
Authority
KR
South Korea
Prior art keywords
dihydroxy
methylpyrrolidine
formula
compound
amine
Prior art date
Application number
KR1019950007864A
Other languages
English (en)
Other versions
KR0164458B1 (ko
Inventor
박호군
이용섭
이재열
석대환
우은란
Original Assignee
김은영
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김은영, 한국과학기술연구원 filed Critical 김은영
Priority to KR1019950007864A priority Critical patent/KR0164458B1/ko
Priority to US08/522,792 priority patent/US5675003A/en
Priority to JP7324681A priority patent/JP2675539B2/ja
Publication of KR960037685A publication Critical patent/KR960037685A/ko
Application granted granted Critical
Publication of KR0164458B1 publication Critical patent/KR0164458B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

다음 일반식(Ⅰ)의 신규한 3-프로페닐 세팔로스포린 화합물 및 그의 제조방법이 제공된다. 본 발명의 암모니오프로페닐 세팔로스포린 화합물은 특히 세팔로스포린계 항생제에 내성이 강한 균주인 엔테로박터 클로아케 P99에 대해 기존의 광범위 항생제로서 널리 알려진 세프타지딤보다 월등한 항균력을 보일뿐 아니라 그램 양성균에 대해서도 세프타지딤보다 우수한 항균력을 나타낸다.
식 중, P는 상기 정의된 바와 같다.

Description

암모니오세팔로스포린 계열 항생제 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 다음 일반식(Ⅰ)의 신규한 3-프로페닐 세팔로스포린 화합물 또는 이들의 약학적으로 허용되는 염.
    상기 일반식(Ⅰ)에서 P는 하나의 질소를 갖는 동시에 한 개 또는 두 개의 히드록실기를 갖는 비고리형 아민 또는 헤테로시클릭아민으로서 메조-3,4-디히드록시-1-메틸피롤리딘, (3S,4S)-3,4-디히드록시-1-메틸피롤리딘, (3R,4R)-3,4-디히드록시-1-메틸피롤리딘, (2S,4R)-4-히드록시-1-메틸-2-필로리딘메탄올, N-메틸-비스(2-히드록시에틸)아민, 3,4-시스-디히드록시-1-메틸피레리딘, 3,4-트란스-디히드록시-1-메틸피롤리딘, 4-히드록시-1-메틸피페리딘, 2-히드록시메틸-1-메틸피페리딘, 또는 트로핀이다.
  2. 다음 일반식(Ⅲ)의 아민 화합물 P를 다음 일반식(Ⅱ)의 화합물과 반응시키는 것으로 이루어지는 제1항에 따른 일반식(Ⅰ)의 세팔로스포린 화합물의 제조방법.
    식 중 X는 할로겐 원자이다.
    P (Ⅲ)
    식 중, P는 메조-3,4-디히드록시-1-메틸피롤리딘, (3S,4S)-3,4-디히드록시-1-메틸피롤리딘, (3R,4R)-3,4-디히드록시-1-메틸피롤리딘, (2S,4R)-4-히드록시-1-메틸-2-피롤리딘메탄올, N-메틸-비스(2-히드록시에틸)아민, 3,4-시스-디히드록시-1-메틸피레리딘, 3,4-트란스-디히드록시-1-메틸피롤리딘, 4-히드록시-1-메틸피페리딘, 2-히드록시메틸-1-메틸피페리딘 또는 트로핀임.
  3. 제2항에 있어서, 일반식(Ⅲ)의 아민 화합물에를 일반식(Ⅱ)의 화합물과 반응시키기 전에, 2 내지 5당량의 실릴화제에 의해 실릴화시키는 것이 특징인 방법.
  4. 제3항에 있어서, 실릴화제가 N-메틸트리메틸실릴트로플루오로아세트아미드(MSTFA), N,O-비스트리메틸실릴트리플루오로아세트아미드(BSTFA), 헥사메틸디실라잔(HMDS), N,O-비스트리메틸실릴아세트아미드(BSA), 비스트리메틸실릴유레아, 및 N-메틸트리메틸실릴아세트아미드 중에서 선택되는 것이 특징인 방법.
  5. 유효성분으로서 제1항에 따른 일반식(Ⅰ)의 3-프로페닐 세팔로스포린 화합물과 약리학적으로 허용되는 담체로 된 항생제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019950007864A 1995-04-04 1995-04-04 암모니오세팔로스포린 계열 항생제 및 그의 제조방법 KR0164458B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1019950007864A KR0164458B1 (ko) 1995-04-04 1995-04-04 암모니오세팔로스포린 계열 항생제 및 그의 제조방법
US08/522,792 US5675003A (en) 1995-04-04 1995-09-01 3-ammoniopropenyl cephalosporin compounds as antibacterial agents
JP7324681A JP2675539B2 (ja) 1995-04-04 1995-12-13 アンモニオセファロスポリン系列抗生剤及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950007864A KR0164458B1 (ko) 1995-04-04 1995-04-04 암모니오세팔로스포린 계열 항생제 및 그의 제조방법

Publications (2)

Publication Number Publication Date
KR960037685A true KR960037685A (ko) 1996-11-19
KR0164458B1 KR0164458B1 (ko) 1999-01-15

Family

ID=19411540

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950007864A KR0164458B1 (ko) 1995-04-04 1995-04-04 암모니오세팔로스포린 계열 항생제 및 그의 제조방법

Country Status (3)

Country Link
US (1) US5675003A (ko)
JP (1) JP2675539B2 (ko)
KR (1) KR0164458B1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872249A (en) * 1995-09-01 1999-02-16 Korea Institute Of Science And Technology 3-ammoniopropenyl cephalosporin compounds as antibacterial agents and process for preparing the same
US6433818B1 (en) 1998-11-06 2002-08-13 Fotonation, Inc. Digital camera with biometric security
US6891567B2 (en) * 1998-06-26 2005-05-10 Fotonation Holdings, Llc Camera messaging and advertisement system
US7324133B2 (en) 1998-11-06 2008-01-29 Fotomedia Technologies, Llc Method and apparatus for controlled camera useability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
GB2025398B (en) * 1978-05-26 1982-08-11 Glaxo Group Ltd Gephalosporin antibiotics
US4486586A (en) 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
JP2904810B2 (ja) * 1989-06-22 1999-06-14 エーザイ株式会社 ７―チアゾリルアセトアミド―３―プロペニルセフェム誘導体
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten

Also Published As

Publication number Publication date
US5675003A (en) 1997-10-07
KR0164458B1 (ko) 1999-01-15
JP2675539B2 (ja) 1997-11-12
JPH08283274A (ja) 1996-10-29

Similar Documents

Publication Publication Date Title
UA37181C2 (uk) ГІДРОХЛОРИД 7-<font face="Symbol">b</font>-[(Z)-2-(2-АМІНО-4-ТІАЗОЛІЛ)-3-ГІДРОКСИІМІНОАЦЕТА- МІДО]-3-(1,2,3-ТРИАЗОЛ-4-ІЛ)ТІОМЕТИЛТІО-3-ЦЕФЕМ-4-КАРБОНОВОЇ КИСЛОТИ АБО ЙОГО ГІДРАТИ, ЩО МАЮТЬ АНТИБАКТЕРІАЛЬНУ ДІЮ, ФАРМАЦЕВТИЧНА АНТИБАКТЕРІАЛЬНА КОМПОЗИЦІЯ, СПОСІБ ПРИГНІЧЕННЯ РОЗВИТКУ БАКТЕРІЙ, СПОСІБ ЛІКУВАННЯ БАКТЕРІАЛЬНИХ ІНФЕКЦІЙ
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
CA2233666A1 (en) Heterocyclic fungicides
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
BR0214164A (pt) Ligantes do receptor canabinóide
PT854874E (pt) Compostos de lactona macrociclica e seu processo de producao
NO996108L (no) 9-oksinerytromycinderivater
CA2275166A1 (en) Novel benzopyran derivatives
MX9300278A (es) Compuestos de arilalcoxifenoxi-imidazolina.
AU7001996A (en) Novel derivatives of cyclodepsipeptide PF1022 substance
FI970427A0 (fi) Menetelmä mikrobinvastaisten yhdisteiden valmistamiseksi
NZ308518A (en) Antibacterial cephalosporins
CA2234319A1 (en) Fluoro-substituted adamantane derivatives
HUP0001741A2 (hu) Antibakteriális hatású aza-biciklo-karbamoil-oxi-mutilin-származékok, eljárás ezek előállítására, ezeket tartalmazó készítmények és alkalmazásuk
KR960037685A (ko) 암모니오세팔로스포린 계열 항생제 및 그의 제조방법
ATE219085T1 (de) 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren
YU69699A (sh) Derivati aril karbonske kiseline i tetrazola
AU654300B2 (en) 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation
CA2382654A1 (en) Novel a-500359 derivatives
EP0702014A4 (en) DC-89 DERIVATIVES
KR950000710A (ko) 세팔로스포린계 항생제 및 그의 제조방법
IE830800L (en) Pyrrolinoazetidinone derivatives
CA2187849A1 (en) Uck14 compounds
TW371304B (en) Cephem compounds having antibacterial activity, their production and pharmaceutical composition
KR890006643A (ko) β-락탐 항생물질의 모노하이드레이트 및 용매화합물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030730

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee